Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has helped millions lose weight, but it is not appropriate for everyone. Specific medical histories, genetic predispositions, and medication interactions require careful screening before starting any GLP-1 therapy. PlexusDx conducts comprehensive health reviews to identify who should avoid or modify semaglutide treatment and explore safer alternatives.
Personal or Family History of Thyroid Cancer
Semaglutide carries a black-box warning for thyroid C-cell tumors based on rodent studies. People with a personal history of medullary thyroid carcinoma or a family history of multiple endocrine neoplasia type 2 must not take semaglutide, according to FDA labeling. This restriction exists even though human clinical trials have not documented this risk, because the animal data raised enough concern to warrant strict avoidance.
PlexusDx screens all applicants for thyroid cancer history and known genetic syndromes linked to thyroid malignancy. If you have these risk factors, PlexusDx can discuss alternative weight-loss compounds or non-peptide strategies that do not carry thyroid-related warnings.
Pregnancy, Breastfeeding, and Reproductive Planning
Semaglutide has not been studied in pregnant people and is classified as a Category C medication for pregnancy risk. Animal studies showed fetal harm at high doses, which means the drug should be avoided during pregnancy and for at least two months before conception if possible. People who are breastfeeding should also avoid semaglutide, as it is unknown whether the compound passes into breast milk or could harm an infant.
Women and people assigned female at birth who plan to become pregnant within the next two to three years should discuss non-hormonal, non-peptide weight-loss options with PlexusDx. Stopping semaglutide requires a washout period, so family-planning timelines matter when selecting a therapy.
History of Pancreatitis or Gallbladder Disease
GLP-1 receptor agonists like semaglutide increase the risk of acute pancreatitis and can worsen gallbladder disease. People with a prior episode of acute pancreatitis face a higher chance of recurrence, and semaglutide may trigger inflammation. Similarly, those with active gallstones or a history of biliary colic should avoid semaglutide unless benefits clearly outweigh risks and a doctor provides close monitoring.
PlexusDx evaluates your gastrointestinal and biliary history before recommending semaglutide. If you have had pancreatitis or gallbladder issues, PlexusDx may suggest the Microdose GLP-1 Protocol or other personalized compounds that carry lower pancreatitis risk while still supporting metabolic health.
Severe Kidney Disease and Medication Interactions
While semaglutide does not require dose adjustment in mild to moderate kidney disease, severe renal impairment (eGFR below 15) has not been adequately studied. Additionally, semaglutide can cause dehydration and acute kidney injury, particularly when combined with certain diabetes medications or diuretics. People taking SGLT2 inhibitors, ACE inhibitors, or thiazide diuretics need extra scrutiny when considering semaglutide.
PlexusDx reviews all medications and supplements you take, including over-the-counter pain relievers and herbal products. A personalized medication audit helps identify contraindications and unsafe drug combinations before you start any compounded semaglutide therapy. If your kidney function or medication profile makes semaglutide risky, PlexusDx explores safer peptide alternatives or hybrid protocols.
Genetic Predisposition and Personalized Screening
Some people have genetic variants that affect how they respond to GLP-1 compounds or increase their risk of side effects. The Precision Peptide Genetic Test from PlexusDx analyzes key variants in the GLP1R, GIPR, FTO, and MC4R genes, revealing individual peptide-pathway activity and personalized risk patterns. This test ($99 add-on after first month of treatment) helps predict whether semaglutide or alternative compounds like tirzepatide may work better for you.
Genetic screening does not replace medical contraindication review, but it strengthens personalization. PlexusDx combines genetic insights with your complete health history to recommend the safest and most effective weight-loss therapy. Even if semaglutide is medically appropriate, genetic data may point to a dual-compound protocol like GLP-Squared or microdose GLP-1 as a better fit.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take semaglutide if I have type 2 diabetes and kidney disease?
If your kidney disease is mild to moderate, semaglutide is often safe and may help your diabetes. However, severe kidney impairment (eGFR below 15) requires specialist input and closer monitoring. PlexusDx reviews your lab work and medication list to confirm semaglutide is appropriate or suggest a safer alternative like the Microdose GLP-1 Protocol starting at $129/month.
What if I have a family history of thyroid cancer but no personal history?
Family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 is a contraindication for semaglutide. Even without personal disease, the genetic risk justifies avoiding GLP-1 compounds. PlexusDx can discuss non-peptide weight-loss strategies or genetic testing to clarify your individual risk before ruling out all options.
Why does PlexusDx charge a flat monthly price instead of a per-dose cost?
PlexusDx charges a flat monthly rate ($149–$189/month for compounded semaglutide injection depending on your commitment tier) because your dose may need to go up—your price won't. This model removes cost barriers to safe dose escalation and ensures affordability as you find your therapeutic level.
Can I take semaglutide if I'm planning to get pregnant?
No. Semaglutide should be stopped at least two months before trying to conceive because animal studies showed fetal harm. If you plan pregnancy within two to three years, discuss non-peptide options now with PlexusDx, including lifestyle support and other compounds that are safer in reproductive planning.
How does the Precision Peptide Genetic Test help identify who should avoid semaglutide?
The Precision Peptide Genetic Test ($99 add-on) analyzes 14 pathways and 150+ genetic insights, including GLP1R, GIPR, FTO, and MC4R variants. While it does not diagnose contraindications, it reveals your individual peptide-pathway activity and may show that tirzepatide, dual-compound therapy, or microdose protocols are safer and more effective than semaglutide alone.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Does My Mounjaro Injection Site Hurt? Understanding Injection Site Reactions
What Food to Avoid While Taking Ozempic